Clinical Trials Directory

Trials / Completed

CompletedNCT01197183

Observational Study With Prospective and/or Retrospective Follow-up, Without Modifying Patient Treatment and Follow-up Practices for the Initial Treatment of Hypothyroidism in France

Survey for the Initial Treatment of Hypothyroidism in France

Status
Completed
Phase
Study type
Observational
Enrollment
1,285 (actual)
Sponsor
Merck KGaA, Darmstadt, Germany · Industry
Sex
All
Age
35 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This observational survey with prospective and/or retrospective follow-up is designed to study practices for the initial treatment of hypothyroidism in France without modifying subject treatment.

Detailed description

Thyroid disorder can be central, caused by a deficiency in thyroid stimulating hormone (TSH) production; or peripheral, caused by the decrease in the plasma concentration of thyroid hormones, more specifically of free thyroxine (free T4). Peripheral hypothyroidism is caused by the decrease in the production capacities of the thyroid gland. The treatment of hypothyroidism is based on the restoration and maintenance of biological (judged on the basis of the standardised TSH and T4 values) and clinical euthyroidism. A number of forms of thyroid hormones are available in the French market (Euthyral®, Cynomel®, L-thyroxine drops®), of which, Levothyrox® is the most frequently prescribed drug in this category. The treatment of peripheral hypothyroidism, in particular, is well codified and almost consensual. In France, there is no published observational study, based on which one can document the manner in which subjects are treated. This observational study is set up to document these practices. OBJECTIVES The principal objectives of this survey is to to get information on the use of Levothyrox in France * Circumstances of diagnosis * Record realised * Terms and conditions of treatment by the general practitioner and/or the endocrinologist The secondary objective is to evaluate the inclusion criteria for levothyroxine treatment. For each subject the participating doctor will complete a follow up questionnaire form until the first control level of TSH after the diagnosis of hypothyroidism.

Conditions

Timeline

Start date
2008-10-01
Primary completion
2009-05-01
Completion
2009-09-01
First posted
2010-09-09
Last updated
2014-02-04

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01197183. Inclusion in this directory is not an endorsement.